Xvivo Perfusion AB (publ) (XVIPY)
OTCMKTS
· Delayed Price · Currency is USD
11.45
-0.80 (-6.53%)
Oct 25, 2024, 2:26 PM EDT
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of $1.03 billion as of May 16, 2025. Its market cap has decreased by -5.03% in one year.
Market Cap
1.03B
Enterprise Value
1.00B
Revenue
85.18M
Ranking
n/a
PE Ratio
75.62
Stock Price
$11.45
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 56.07M to 1.03B, an increase of 1,740.55%. That is a compound annual growth rate of 25.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Veradigm | 755.08M |
| Nika Pharmaceuticals | 672.83M |
| Tian'an Technology Group | 591.73M |
| Glass House Brands | 521.91M |
| CytoDyn | 485.65M |
| Elite Pharmaceuticals | 482.44M |
| Northwest Biotherapeutics | 416.61M |